FilingReader Intelligence
Aurobindo Pharma Q1 revenue rises but profit falls
August 4, 2025 at 02:19 PM UTC•By FilingReader AI
Aurobindo Pharma reported Q1 revenue of INR 7,868 crore, up 4.0% year-on-year, but net profit fell 10.2% to INR 824 crore. US revenue declined 1.9% to INR 3,488 crore.
The company received 14 final USFDA approvals and launched 15 products. Its biosimilar Dazublys received EU marketing authorization.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:AUROPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Aurobindo Pharma publishes news
Free account required • Unsubscribe anytime